Liquidia Technologies Inc（纳斯达克：LQDA）首席执行官兼董事罗杰·杰夫斯近日披露减持公司普通股。详细交易情况已通过美国证券交易委员会EDGAR系统提交正式文件披露，相关公告文件可通过文末链接获取。
根据监管文件显示，此次股权变动发生于近期，标志着公司高层管理人员对持股结构的主动调整。作为生物技术领域的重要企业，Liquidia专注于肺部疾病治疗技术的研发，其高管持股变动通常受到市场密切关注。
投资者可通过美国证交会指定数据库查询完整备案材料，该文件包含具体交易日期、股数及交易价格等关键细节。请点击查阅：https://www.sec.gov/Archives/edgar/data/0000000000/000000000000000000/0000000000-00-0000000-index.htm
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.